Cell to cell communication facilitates tissue development and physiology. Under pathological conditions, brain tumors disrupt glia-neuron communication signals that in consequence, promote tumor expansion at the expense of surrounding healthy tissue. The glioblastoma is the most aggressive and frequent brain tumor. This type of glioma expands and infiltrates into the brain, causing neuronal degeneration and neurological decay, among other symptoms. Here we describe how the glioblastoma produce ImpL2, an antagonist of the insulin pathway, which is regulated by the microRNA miR-8. ImpL2 targets neighboring neurons and causes mitochondrial disruption as well as synapse loss, both early symptoms of neurodegeneration. Furthermore, glioblastoma progression requires insulin pathway attenuation in neurons. Restoration of neuronal insulin activity is sufficient to rescue the synapse loss and to delay the premature death caused by glioma. Therefore, signals from GB to neuron emerge as a potential field of study to prevent neurodegeneration and to develop anti-tumoral strategies.
Introduction
Cancer is one of the leading causes of mortality worldwide and is expected to be responsible for 15 million deaths in 2020 (65% in less developed countries) according to the World Health Organization. Notwithstanding recent advances in health treatments and extended lifespan of patients, some tumors still remain incurable. Among them, glioblastoma (GB) stands out because it is the most frequent and aggressive primary brain tumor. It is originated from glial cells and causes death within the first year after diagnosis (1), despite standard treatments such as resection, radiotherapy, and chemotherapy. This is accompanied by broad neurological dysfunctions (2). Brain tumors cause characterized by anorexia and metabolic alterations induced by other malignant tumors (28). Secreted ImpL2 from epithelial tumor cells induces systemic organ wasting and insulin resistance by antagonizing insulin signaling (29, 30) .
Interestingly, PI3K and Drosophila Ras homolog enriched in brain (dRheb), two members of the insulin pathway, induce the formation of synapsis between neurons (a process known as synaptogenesis) in the Drosophila larval brain (31). Actually, it has been shown that AKT, also involved in insulin signaling, acts as a pro-synaptogenic element (32) . These data strongly support a role for insulin signaling in the regulation of neuronal synaptic activity in Drosophila. In mammals, a similar effect of insulin signaling on synaptic plasticity has been described (33). Notably, synapse loss is an early step in neurodegeneration (34, 35) . We have recently re-evaluated GB as a neurodegenerative disease, showing that GB reduces the number of synapsis through wingless/frizzled 1 (wg/fz1) signaling (Portela et al, PLOS Biol 2019) , equivalent to mammalian WNT pathway (36). However, whether tumoral glial cells are able to modify insulin signaling directly in neurons, and consequently alter the number of synapses, is yet unknown.
In this report, we show that secreted ImpL2 from glial-derived tumoral cells antagonizes insulin signaling in neighboring neurons, inducing a reduction in synapse number and consequently promoting neurodegeneration. ImpL2 expression in GB cells is regulated by miR-8, thus linking functionally micro-RNA pathway with Insulin signaling in a GB model. We describe the function of ImpL2 as a mediator in GB-neuron communication, responsible for the reduction in synapse number and neurological defects. Indeed, we propose the insulin pathway as a core signal in GB progression and neurological decay.
Finally, we propose a novel neuroprotective strategy against GB that extend lifespan and improve life quality.
Results

ImpL2 mediates GB progression and neurodegeneration
To study the mechanisms of communication among malignant glial cells and neurons, we used a previously well-characterized Drosophila GB model that stimulates the oncogenic transformation of glial cells and lethal glial neoplasia in post-embryonic larval (14, 16) or adult brains (10), leading to lethal glial neoplasia. We previously reported a reduction in the number of synapses in the neuromuscular junction (NMJ) of adult flies caused by GB progression (Portela et al, 2019) . This neurodegenerative process is observed even though those genetic modifications were caused in glial cells. This phenomenon suggests that signals originated in the glial tumor impact on neighboring neurons. Synaptogenesis is tightly regulated by PI3K, a main player in insulin signaling pathway (32) . Moreover, the expression of secreted molecules that decrease insulin pathway activity, such as ImpL2 (IGFBP7 in humans), correlates with GB progression (23, 24) .
To determine ImpL2 mRNA expression levels in GB we performed qPCR experiments. ImpL2 mRNA shows an increase in GB samples as compared to control brains ( fig 1A) . To discriminate ImpL2 expression in neuronal or glial (GB) cells, we used a MIMIC GFP reporter that reproduces faithfully ImpL2 expression (37). Consistently, GB cells show higher GFP levels than control glial cells. Likewise, upon ImpL2 RNAi expression we detect a decrease in GFP levels, similar to the ones observed in control brains (fig 1B-D) . In a previous work we established that tumoral progression depends on the formation of a network of protrusions (i.e. an expansion of the membrane surface) named tumor microtubules (TMs), similarly to human GB (17, 38) . Besides, in mammals and flies the TM network requires the GAP43 and igloo gene functions, respectively (17, 38) . We also showed that GB progression requires c-Jun N-terminal Kinase (JNK) pathway activity (17) . The Drosophila JNK homolog basket (bsk) plays a central role in JNK signaling in normal and tumoral conditions (39). We overexpressed igloo RNAi and a dominant negative form of bsk to block TM formation and JNK activity, respectively. As expected, ImpL2 expression levels are reverted to similar levels to the ones observed in controls brains in both cases ( fig 1E-F) . Indeed, the analysis of co-localization rate between ImpL2 and glial cells shows a significant increase in ImpL2 levels specifically in GB cells ( fig 1G) .
To detect signs of neurodegeneration, we quantify the number of synapses in the neuromuscular junction (NMJ) of the adult flies with GB. NMJ is a stereotyped structure that allows to count the number of synapses (i.e.synapsessynapses) in the synaptic buttons of the motoneurons by using anti-bruchpilot, an specific antibody that recognizes synapses unambiguously (see material and methods for details). To determine the contribution of ImpL2 to synapse loss, we knockdown ImpL2 in GB cells and counted the number of synapsessynapses in adult NMJs. The results show that ImpL2 reduction in GB cells counteracted the reduction in the number of synapsessynapses of GB brains ( Thus, we conclude that GB cells upregulate and secrete ImpL2, a necessary step to induce tumoral expansion and a reduction of the synapse number in surrounding neurons.
microRNAs regulate ImpL2 expression in GB
It has been described that low levels of micro-RNAs correlate with high levels of ImpL2 homolog in human GB, suggesting that ImpL2 regulation might be mediated by microRNAs (23). Accordingly, there is a down-regulation of the microRNA miR-200 family in GB samples (reviewed in (21)) Given that miR-8, the Drosophila homologue of miR-200 family, negatively regulates ImpL2 mRNA stability in the fat body (40), we hypothesize that miR-8 may play a role in GB progression by regulating ImpL2 levels. We used a miR-8 sensor to monitor miR-8 activity. It includes miR-8 binding sites in the 3´UTR of the GFP gene (41). Thus, high levels of GFP indicate low levels of miR-8 activity, and vice versa (see Materials and Methods). GFP signal is increased in GB cells (fig 3A-C), indicating that miR-8 levels are reduced. To determine if the increase of ImpL2 in GB depend on miR-8, we analyzed ImpL2 sensor upon miR-8 overexpression in that context. We observed a significant reduction of ImpL2 expression in GB cells in vivo. Consistently, miR-8 gain-of-function in GB partially rescues the loss of synapses, recapitulating the effect of ImpL2 loss-of- Altogether these results show an inverse correlation between miR-8 and ImpL2 expression in GB cells and suggest that ImpL2 levels are regulated by miR-8 in vivo.
GB secreted ImpL2 reduces neuronal Insulin signaling
To evaluate the impact of Insulin signaling reduction in neurons, we measure dRheb mRNA by qPCR. dRheb is the molecular link between the insulin signaling pathway and TOR kinase, and it reflects the Insulin pathway activity (reviewed in (42)): dRheb mRNA levels drop down when Insulin signaling is low (43). We analyzed dRheb expression levels in control and GB brains by qPCR. The GB itself is induced by overexpressing a constitutively active form of PI3K, thus the insulin pathway is activated in all glial cells.
However, mRNA levels of dRheb are reduced in GB brains when compared with control brains, suggesting that this increase reflects mostly neuronal expression ( fig 4E) .
To further analyze insulin-dependent TOR activity we used a THOR-MIMIC line. The gene thor encodes for a protein that is involved in translational control. It is regulated by TOR and its expression can hence be used as a surrogate of TOR activity. In normal conditions, thor transcription remains at low but detectable levels (45). However, when Insulin activity is compromised, thor is highly transcribed, as reflected by . Neurons confronted with GB cells have reduced Insulin signaling, as shown by THOR-MIMIC GFP expression. This effect on Insulin pathway is restored by downregulating ImpL2 in GB cells (fig 4A-D). All these results together suggest that ImpL2 up-regulation in GB cells mediates the decreased insulin pathway activity detected in neurons.
However, the central function for insulin signaling pathway related to synaptogenesis was described mainly in larval NMJ synapsis (31). Whether or not insulin signaling plays a similar role in the central adult nervous system has not been evaluated yet. To do so, we expressed a dominant negative form of the insulin receptor (InR) in motor neurons and quantified the number of synapses. The number of synapses was reduced when compared to the control (fig 4F-I). Moreover, high levels of secreted ImpL2 from glial cells also shows a reduction in the synapse number, thus suggesting that the ImpL2 effect on synapsis is due to a deregulation of the insulin signaling in neurons.
Insulin signaling in neurons mediates neurodegeneration and mortality in
GB.
Our results suggest that in a GB ImpL2 overexpression causes an effective decrease in neuronal Insulin pathway activity which in turn induces neurodegeneration. If this is true, restoring Insulin signaling specifically in neurons should prevent GB-induced neurodegeneration. However, in order to manipulate Insulin pathway activity in neuronal population simultaneously with GB induction in glial cells, we needed to use the LexA/LexAOp system (see Insulin signaling mediates glucose metabolism and mitochondrial physiology (47). Additionally, mitochondrial alterations are related to synapse dysfunction and neurodegeneration (48) (49). In particular, the transport of mitochondria through the axons is altered in other neurodegenerative diseases (50). Therefore, we investigated if GB progression affects neuronal mitochondria.
We used a lexAop-mitocherry reporter transgene to quantify the distribution of mitochondria in axon terminals. Pixel intensity quantification showed that GB causes a significant increase of mitochondria in the neuronal 
DISCUSSION
GB is the most aggressive type of brain tumor. During GB progression tumoral cells extend a network of membrane projections that contribute to brain infiltration and results in poor prognosis for the patient. GB courses with a neurological decay that includes drowsiness, sleep disturbances, speech difficulties and other typical symptoms of neurodegeneration (3). For decades the origin of this decay was attributed to the high pressure caused by the GB solid mass and the associated edema. Despite the solid mass of the GB being removed after surgery, the neurodegenerative process continues, more likely due to the diffuse GB progression. This indicates that mechanisms underlying neurological decay are not restricted to the intracranial pressure and edema.
Recent publications suggested an active communication between GB cells and the surrounding healthy tissue, including neurons. Experiments done with human GB cells in mice xenografts revealed a physical interaction between GB cells and neurons as electrical and chemical synapses (54, 55) . In this case neurons act as presynaptic structures whereas GB tumoral cells are postsynaptic elements. These so-called "synapses" are required for GB progression. Besides, we have recently described cellular mechanisms for GB to deplete Wingless (Wg)/WNT from neurons. GB cells project TMs that enwrap neurons and accumulate Frizzled1 (Fz1) receptor to vampirize Wg from neighboring neurons. This unidirectional mechanism facilitates GB proliferation and cause a loss of synapses in the neurons (17). Finally, here we also describe a one-way communication system from GB cells towards neurons. ImpL2 protein is originated in GB cells and target healthy neurons, but not viceversa. ImpL2 binds InR ligands and act as an antagonist of the pathway. In consequence, insulin signaling is reduced in neurons which in turn cause mitochondrial aberrations, synapse loss and lethality (fig 7) . Neuronal insulin signaling can be restored via Rheb upregulation, and this is sufficient to extend the lifespan of GB animals. These results suggest that reducing insulin signaling (and the subsequent neurodegeneration) is critical for GB proliferation, progression and invasion, and ultimately for the lethality caused by GB.
The regulation of ImpL2 expression in GB cells seems to depend on microRNAs, at least in part. In cancer, micro-RNAs have emerged as general regulators key for tumoral progression, including GB (20). Interestingly, miR-200 family (miR-8 in Drosophila) play a key role in human GB. We have described the presence and relevance of miR-8 in GB progression as a regulator of ImpL2 expression. However, there are no predicted miR-8 binding sites in ImpL2 sequence; therefore, it is unlikely that miR-8 regulates directly ImpL2 mRNA stability. One possibility is the existence of mediator proteins that depend directly on miR-8. The most evident possibility is a transcription factor whose mRNA stability is sensitive to miR-8 and acts as a transcriptional regulator of ImpL2. However, the regulation of ImpL2 and the association to microRNAs is a matter for future studies. Another intriguing point is the differential effects that both miR-8 overexpression and ImpL2 down-regulation have on GB growth.
Whereas an excess of miR-8, that in turn reduces ImpL2, is unable to reduce GB cell number, direct downregulation of Impl-2 significantly reduces the growth of GB cells. Nevertheless, it is known that most of microRNAs control several mRNAs, thus miR-8 overexpression might affect to different extent other mRNAs than just ImpL2 mRNA, which may account for such differences.
Altogether, our data suggest that the progression of brain tumors in Drosophila depends not only in the intrinsic properties of the tumoral cells, but also in the physiological condition of the surrounding cells (fig 7) . GB patients respond differently to the progression of the GB: some patients survive for a few months whereas others survive for years. If we accept that the coordinated effect in GB and neurons result in differential tumor progression, the vast differences in how patients respond to GB could be, in part, dependent on genetic or epigenetic conditions related to InR signaling genes in neurons, and probably other pathways such as WNT or Hedgehog.
Materials and methods
Fly stocks and genetics
All fly stocks were maintained at 25ºC (unless otherwise specified) on a 12/12h light/dark cycles at constant humidity in standard medium. The stocks used from Bloomington Stock Center were: tub-Gal80 ts (BL-7019), Repo-Gal4 (BL-7415), The glioma-inducing line contains the UAS-dEGFR λ , UAS-dp110 CAAX transgenes that encodes for the constitutively active forms of the human orthologues PI3K and EGFR respectively (16). Repo-Gal4 line drives the Gal4 expression in every glial cell (57) and combined with the UAS-dEGFR λ , UAS-dp110 CAAX line allow us to generate a glioma thanks to the Gal4 system (58). Elav-LexA line drives the expression to neurons (59), allowing us to manipulate neurons in a glioma combining LexA and Gal4 expression systems (60).
Gal80 TS is a repressor of the Gal4 activity at 18ºC, though at 29ºC is inactivated (McGuire et al., 2003) . The tub-Gal80 ts construct was used in all the crosses to avoid the lethality caused by the glioma development during the larval stage. The crosses were kept at 17ºC until the adult flies emerged. To inactivate the Gal80 ts protein and activate the Gal4/UAS system to allow the expression of our genes of interest, the adult flies were maintained at 29ºC for a period indicated in each experiment.
Immunostaining and Image acquisition
Adult brains were dissected and fixed with 4% formaldehyde in phosphate-buffered saline for 20 minutes whereas adult NMJ were fixed 10 minutes; in both cases, samples were washed 3x15 min with PBS+0.4% triton, blocked for 1 h with BSA 1%, incubated overnight with primary antibodies, washed 3x15 min, incubated with secondary antibodies for 4 h and mounted in Vectashield mounting medium with DAPI. The primary antibodies used were anti-repo mouse (1/200, DSHB), antibruchpilot -NC82-mouse (1/50, DSHB), anti-HRP rabbit (1/400, Cell Signalling) anti-GFP rabbit (1:500, DSHB). The secondary antibodies used were Alexa 488 or 647 (1/500, Life Technologies). Images were taken by a Leica SP5 confocal microscopy. To quantify synapses and number of glial cells, we analyzed confocal images with the Imaris software (www.bitplane.com). It allows to select intensity points of a specific diameter that correspond either to the synapses (0.5 µm) or glial cell nuclei (2 µm). Using this software, it is also possible to determine the volume of the glial membrane. For the analysis of pixel intensity, the "measurement log" tool of Photoshop CS5 was used. For the analysis of co-localization rates, "colocalization" tool from LAS AF Lite software (Leica) was used.
RNA extraction, reverse transcription and qPCR
For RNA extraction, 1-to 4-day-old male adults were entrained to a 12:12 h LD cycle for 7 days at 29ºC and then collected on dry ice at ZT 6. Total RNA was extracted from 30 heads of adult males of the Control (repo>LacZ), Glioma (repo> UAS-dEGFR λ , UAS-dp110 CAAX ) and repo> UAS-dEGFR λ , UAS-dp110 CAAX , elav-LexA, LexAOp-Rheb genotypes after 7 days of glioma development. RNA was extracted with TRIzol and phenol chloroform. Total RNA concentration was measured by using NanoDrop ND-1000. cDNA was synthetized from 1 mg of total RNA using M-MLV RT (Invitrogen). cDNA samples from 1:5 dilutions were used for real-time PCR reactions. Transcription levels were determined in a 14 mL volume in duplicate using SYBR Green (Applied Biosystem, Foster City, CA) and 7500qPCR (Thermo Fisher, Waltham, MA). We analysed transcription levels of ImpL2, Rheb and Rp49 as housekeeping gene reference.
Sequences of primers were: RP49 F: GCATACAGGCCCAAGATCGT, Rp49 R:
AACCGATGTTGGGCATCAGA, ImpL2 F: CCGAGATCACCTGGTTGAAT, ImpL2 R: AGGTATCGGCGGTATCCTTT, Rheb F: CGACGTAATGGGCAAGAAAT and Rheb R: CAAGACAACCGCTCTTCTCC.
After completing each real-time PCR run, outlier data were analysed using 7500 software (Applied Biosystems). Ct values of triplicates from 3 biological samples were analysed calculating 2DDCt and comparing the results using a t-test with GraphPad (GraphPad Software, La Jolla, CA).
Viability and survival assays.
Lifespan was determined under 12:12 h LD cycles at 29ºC conditions. Three replicates of 30 1-to 4-day-old male adults were collected in vials containing standard Drosophila media and transferred every 2-3 days to fresh Drosophila media.
Electron microscopy
Adult brains of repo>LacZ, repo> UAS-dEGFR λ , UAS-dp110 CAAX and repo> UAS- 
